The Future is Here: How genomes are revolutionizing genetic testing
16, 2021. Dr. Christine Stanley, Chief Director of Clinical Genomics at Variantyx, hosted our virtual NSGC sponsored webinar on November 16, 2021. Dr. Stanley highlighted the advantages of WGS vs. WES, what types of variants WGS can detect, and why clinicians should consider WGS for their patients in our virtual NSGC webinar. Watch the full video below and review our Products & Services.